Beijing, March 2 (SocialNews.XYZ) China conditionally approved the registration application of a self-developed recombinant protein subunit vaccine against Covid-19, the National Medical Products Administration said Wednesday.
The vaccine, developed by Anhui Zhifei Longcom Biopharmaceutical Co, Ltd., was allowed to enter the market on a conditional basis, said the administration, Xinhua news agency reported.
It marked the first approved Covid recombinant protein subunit vaccine in China.
Source: IANS
Gopi Adusumilli is a Programmer. He is the editor of SocialNews.XYZ and President of AGK Fire Inc.
He enjoys designing websites, developing mobile applications and publishing news articles on current events from various authenticated news sources.
When it comes to writing he likes to write about current world politics and Indian Movies. His future plans include developing SocialNews.XYZ into a News website that has no bias or judgment towards any.
He can be reached at gopi@socialnews.xyz
This website uses cookies.
